Moreover, highly expressed LOX-1 is a significant prognosis factor of tumor progression in advanced-stage of prostate cancer and colorectal cancer (González-Chavarría et al., 2018; Nakashima-Nakasuga et al., 2020). The gene discussed is OLR1; the disease is neoplasm.